4//SEC Filing
Higgons John Duncan 4
Accession 0001640455-21-000017
CIK 0001640455other
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 6:39 PM ET
Size
6.4 KB
Accession
0001640455-21-000017
Insider Transaction Report
Form 4
Higgons John Duncan
Director
Transactions
- Sale
Common Stock
2021-01-20$12.00/sh−1,500$18,000→ 10,513 total - Sale
Common Stock
2021-01-21$11.11/sh−200$2,222→ 10,313 total
Footnotes (2)
- [F1]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 6, 2019. The Reporting Person exercised no discretion with respect to these transactions.
- [F2]The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 21, 2020. The Reporting Person exercised no discretion with respect to these transactions.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
Related Parties
1- filerCIK 0001581954
Filing Metadata
- Form type
- 4
- Filed
- Jan 21, 7:00 PM ET
- Accepted
- Jan 22, 6:39 PM ET
- Size
- 6.4 KB